Global Endocrine, Nutritional and Metabolic Diseases Mortality by Country

The mortality rates due to endocrine, nutritional, and metabolic diseases globally show significant variation across countries. Mexico exhibits the highest mortality at 75.22 thousand female deaths in 2024, with a recent year-on-year increase of 5.27%. Contrastingly, Luxembourg records the lowest at 0.065 thousand deaths, albeit with a modest increase of 1.96% from the previous year. Colombia and Costa Rica have seen notable hikes in mortality, at 12.31% and 19.51% respectively, while South Korea and Slovakia have observed marginal declines. Recent trends highlight considerable disparities among countries, with Eastern European nations generally experiencing lower mortality rates.

Looking forward, several factors could influence future trends in global mortality associated with endocrine, nutritional, and metabolic diseases. These include advancements in healthcare access and management, changing dietary habits, and the aging global population. Continued efforts in preventive healthcare and public awareness are crucial in addressing these disparities and reducing mortality rates in the coming years.